Trials / Completed
CompletedNCT05168059
Clevidipine in Neurocritical Patients
Clevidipine for Acute High Blood Pressure Control in Neurocritical Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 33 (actual)
- Sponsor
- Hospital de Cruces · Academic / Other
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
Acute blood pressure elevation is a frequent problem in neurocritical patients. Its effective management is challenging and must avoid significant decreases of blood pressure leading to lower cerebral perfusion pressure worsening ischemia and elevations probably associated with bleeding, rebleeding or hematoma expansion associated with poor prognosis
Detailed description
Retrospective, observational and single-group study for observe effectiveness and safety of clevidipine for perioperative control of hypertension in patients admitted to Post-Operative Intensive Care Unit after thrombectomy for stroke, intracerebral hemorrhage requiring surgical treatment, embolization of aneurysm after subarachnoid hemorrhage, scheduled neurosurgical and neuroradiology procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clevidipine 0.5 MG/ML Intravenous Emulsion | Effectiveness and safety of clevidipine |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-12-31
- Completion
- 2019-09-01
- First posted
- 2021-12-23
- Last updated
- 2021-12-23
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05168059. Inclusion in this directory is not an endorsement.